Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer Center of the University of Pennsylvania say they’ve identified how to fuel macrophages with … Read more
Researchers at The Institute of Cancer Research, London (ICR) have developed an artificial intelligence (AI) test that analyses the shape of tumour cells to identify patients with aggressive ovarian cancer.
The test is intended to enable tailored treatment based on … Read more
By Regina Schaffer
Swedish women with polycystic ovary syndrome are 15% more likely to develop any cancer vs. women without the condition, with risk further elevated for cancers of the endometrium, ovary, pancreas and kidney, according to a research letter … Read more
By
Researchers have discovered a curious difference between the DNA from cancer cells and that from healthy cells, and this finding could lead to a new blood test for cancer.
The difference? Cancer DNA has a … Read more
By Beth Miller
Researchers have found an innovative way to use sound and light, or photoacoustic, imaging to diagnose ovarian tumors. The method may lead to a promising new diagnostic imaging technique to improve current standard of care for patients … Read more
By Will Boggs MD
The ultrasonographic appearance of ovarian masses is strongly associated with a woman’s risk of ovarian cancer, researchers report.
“Ovarian cancer is a frightening and devastating disease, and we want to be able to find ovarian cancer … Read more
Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.
It is the first time that cancer-associated fibroblasts … Read more
Using ultrasound technology, researchers found simple ovarian cysts—commonly found amongst premenopausal and postmenopausal women—are not associated with an increased risk of ovarian cancer and do not require additional surveillance or surgical intervention, according to research published online
Researchers at Georgia Institute of Technology (Georgia Tech) have developed a new open-source decision support tool designed to help clinicians chose the chemotherapy drug best suited for individual patients.
The open-source support vector machine (SVM)-based algorithm predicted the chemotherapy drug … Read more
By Pam Harrison
All histologic types of ovarian cancer risk lowered in statin versus non-statin users.
Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any histologic type of … Read more
Real-world experience of adverse events with the oral PARP inhibitor niraparib in patients with platinum-sensitive recurrent ovarian cancer at a 200 mg daily dose differed from those most commonly seen in the phase 3 clinical trial at … Read more
Ovarian tumors disable the immune system’s killer T cells—which protect the body by destroying infected or malignant cells—enabling the disease to flourish unchecked, according to a new study by Weill Cornell Medicine scientists. The findings show that adverse conditions within … Read more
The extent to which the BRCA1 promoter is methylated could signal an ovarian tumor’s susceptibility to PARP inhibitor treatment, a new study has found.
PARP inhibitor treatment has been effective in treating some patients with high-grade serous ovarian carcinoma with … Read more
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but never to a cure. About 15 percent of
… Read moreBy Nicola Davis
Researchers not sure apparent protective effect extends to progestin only products such as mini pill and implants.
Women who use modern forms of the combined pill are at a lower risk of developing ovarian cancer than women … Read more
By Elaine K. Howley, Contributor
It’s long been said that the Founding Fathers likely grew and possibly enjoyed using marijuana, or Cannabis sativa. But this notion, which was popularized as the fight to legalize marijuana in the early 2000s
… Read moreLawsuits didn’t do it, public shaming didn’t do it, patients and doctors banding together to “free the data” couldn’t do it: For 22 years Myriad Genetics, one of the oldest genetic testing companies, has refused to make … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
